• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估医疗技术的社会影响。

Assessing the social impacts of medical technologies.

作者信息

Banta H D, Sanes J R

出版信息

J Community Health. 1978 Spring;3(3):245-58. doi: 10.1007/BF01349387.

DOI:10.1007/BF01349387
PMID:721958
Abstract

The introduction of a new medical technology can have indirect, unintended, or unanticipated effects on individuals or on social systems. Although these impacts result from the widespread use of the technology, many of them can be predicted while the technology is being developed. A method for systematically identifying and evaluating these impacts is technology assessment. Such an assessment, made while a technology is being developed, could provide useful information for decision making about research and development and in planning for the technology's eventual introduction. Because only a few medical technologies have been formally assessed and because the process of medical technology development is porrly understood, one must be cautious in recommending widespread use of technology assessment. Nevertheless, enough is now known to permit the formulation of approaches that could be used in preliminary attempts at medical technology assessment.

摘要

新医疗技术的引入可能会对个人或社会系统产生间接、意外或未预料到的影响。尽管这些影响是该技术广泛应用的结果,但其中许多影响在技术研发过程中是可以预测的。系统识别和评估这些影响的方法是技术评估。在技术研发过程中进行这样的评估,可以为有关研发的决策以及该技术最终引入的规划提供有用信息。由于只有少数医疗技术经过了正式评估,而且对医疗技术开发过程了解甚少,因此在建议广泛使用技术评估时必须谨慎。然而,现在已知的信息足以允许制定可用于医疗技术评估初步尝试的方法。

相似文献

1
Assessing the social impacts of medical technologies.评估医疗技术的社会影响。
J Community Health. 1978 Spring;3(3):245-58. doi: 10.1007/BF01349387.
2
Assessment of health information technology: which questions for which systems? Proposal for a taxonomy.健康信息技术评估:针对哪些系统提出哪些问题?一种分类法建议。
Med Inform (Lond). 1993 Jul-Sep;18(3):185-93. doi: 10.3109/14639239309025309.
3
Technology and health care decision making-conceptualizing the process for societal informed consent.
Med Care. 1974 Oct;12(10):845-59. doi: 10.1097/00005650-197410000-00004.
4
Health care technology and the inevitability of resource allocation and rationing decisions. Part II.医疗保健技术与资源分配及配给决策的必然性。第二部分。
JAMA. 1983;249(16):2208-19.
5
Policy formulation and technology assessment.政策制定与技术评估。
Milbank Mem Fund Q Health Soc. 1981 Summer;59(3):445-79.
6
Healthcare costs for new technologies.
Eur J Nucl Med Mol Imaging. 2009 Mar;36 Suppl 1:S139-43. doi: 10.1007/s00259-008-0975-y.
7
[Systematic search for information on ethical issues in HTA reports on medical technologies or interventions].[对医疗技术或干预措施的卫生技术评估报告中的伦理问题信息进行系统检索]
Z Evid Fortbild Qual Gesundhwes. 2008;102(5):329-41. doi: 10.1016/j.zefq.2008.03.001.
8
Technology assessment in medicine.医学中的技术评估。
Acad Med. 1992 Jul;67(7):424-8. doi: 10.1097/00001888-199207000-00002.
9
Planning for "the technology factor".
Hosp Prog. 1978 Sep;59(9):88-92, 94.
10
The dynamics of technological change in medicine.医学领域技术变革的动态
Health Aff (Millwood). 1994 Summer;13(3):28-46. doi: 10.1377/hlthaff.13.3.28.

引用本文的文献

1
Trials and fast changing technologies: the case for tracker studies.试验与快速变革的技术:追踪研究的案例
BMJ. 2000 Jan 1;320(7226):43-6. doi: 10.1136/bmj.320.7226.43.

本文引用的文献

1
Participatory technology.参与式技术
Science. 1971 Feb 19;171(3972):647-53. doi: 10.1126/science.171.3972.647.
2
The new biology: what price relieving man's estate?
Science. 1971 Nov 19;174(4011):779-88. doi: 10.1126/science.174.4011.779.
3
Treatment of acute pulmonary edema: conventional or intensive care?急性肺水肿的治疗:传统治疗还是重症监护治疗?
Ann Intern Med. 1972 Oct;77(4):501-6. doi: 10.7326/0003-4819-77-4-501.
4
Protecting the medical commons: who is responsible?保护医学公共资源:谁来负责?
N Engl J Med. 1975 Jul 31;293(5):235-41. doi: 10.1056/NEJM197507312930506.
5
Measures of clinical efficacy. Cost-effectiveness calculations in the diagnosis and treatment of hypertensive renovascular disease.临床疗效的衡量。高血压性肾血管疾病诊断与治疗中的成本效益计算。
N Engl J Med. 1975 Jul 31;293(5):216-21. doi: 10.1056/NEJM197507312930502.
6
National health expenditures, fiscal year 1975.1975财政年度的国家卫生支出。
Soc Secur Bull. 1976 Feb;39(2):3-20,48.